Perflenapent

N/A

Report date: 2025/06/09 14:19:30
NME

Base Information

Drug NamePerflenapent
Drug Alias Name十二氟戊烷乳液DodecafluoropentanePerfluorocarbonPerfluoropentanePFP +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxygen carriers
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeRespiratory Distress Syndrome, AdultGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNuvox Pharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesNuvox Pharma LLC
Inactive CompaniesN/A
Active IndicationsIschemic StrokeRespiratory Distress Syndrome, AdultGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeV08DA03
Related LinksN/A